Drawing for QUINCE

USPTO serial 97385224

QUINCE

Reviewed by CopyMark Law Group

Reg. 7803872Status 700Registered
Filing date
Status date
Registration date
May 20, 2025
Examiner
PERKINS, ELLEN J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QUINCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey Greene

Jeffrey Greene Foley & Lardner LLP90 Park AvenueNew York, NY 10016-1314United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disordersACTIVESep 26, 2024
042Medical and scientific research; pharmaceutical research and development; pharmaceutical and biological research; pharmaceutical testing; pharmaceutical product development consultation; scientific research in the nature of conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disordersACTIVESep 26, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 20, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 20, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 28, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 28, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 14, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 14, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 4, 2025IUAFUSE AMENDMENT FILED—
Feb 4, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 4, 2025EX3GSOU EXTENSION 3 GRANTED—
Feb 4, 2025EXT3SOU EXTENSION 3 FILED—
Feb 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 23, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 23, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 23, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 1, 2024EX2GSOU EXTENSION 2 GRANTED—
Aug 1, 2024EXT2SOU EXTENSION 2 FILED—
Aug 1, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 19, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 17, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 17, 2024EXT1SOU EXTENSION 1 FILED—
Jan 17, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 8, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 13, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 13, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 24, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 8, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 4, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 4, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2023DOCKASSIGNED TO EXAMINER—
Oct 26, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 3, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 30, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance